Supplementary Table S2 . Figure created in GraphPad Prism (v10.0.2). CKD, chronic kidney disease; CKDu, CKD of uncertain etiology; Cr, creatinine; KIM-1, kidney injury molecule 1; NGAL, neutrophil gelatinase-associated lipocalin. " width="100%" height="100%">
Journal: Kidney International Reports
Article Title: Systematic Review of Kidney Injury Biomarkers for the Evaluation of CKD of Uncertain Etiology
doi: 10.1016/j.ekir.2024.03.013
Figure Lengend Snippet: Urinary concentration of (a) NGAL and (b) KIM-1 by case-control status reported in each study. Each marker represents the mean or median biomarker concentration for the representative subgroup(s) in each study. To facilitate comparisons across normalized and nonnormalized values, values are shown in units of ng/g creatinine or either ng/L for KIM-1, and ng/mg or ng/ml for NGAL. Because approximate urine output is 1L/d and approximate urine creatinine excretion is 1g/d, the units ng/g and ng/l are roughly comparable within an order of magnitude. Data represented in this figure are compiled from the studies of adult populations listed in Supplementary Table S2 . Figure created in GraphPad Prism (v10.0.2). CKD, chronic kidney disease; CKDu, CKD of uncertain etiology; Cr, creatinine; KIM-1, kidney injury molecule 1; NGAL, neutrophil gelatinase-associated lipocalin.
Article Snippet: Figures were made with BioRender.com , Microsoft Excel (version 2311 for Windows; Microscoft Corporation, Redmond, WA), and GraphPad PRISM (version 10.2.1 for Windows; GraphPad Software, Boston, MA).
Techniques: Concentration Assay, Control, Marker, Biomarker Assay